A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

NCT04319367 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

HIV/AIDS and Infections

Interventions

DRUG: Investigational Medicinal Product

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]
[object Object]